168 related articles for article (PubMed ID: 36759298)
1. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations.
Nguyen DD; Labban M; Briggs L; Wallis CJD; Cole AP; Lipsitz SR; Iyer HS; Rebbeck TR; Weissman JS; Choueiri TK; Trinh QD
Urol Oncol; 2023 May; 41(5):252.e9-252.e17. PubMed ID: 36759298
[TBL] [Abstract][Full Text] [Related]
2. Effect of type of definitive treatment on race-based differences in prostate cancer-specific survival.
Frego N; Labban M; Stone BV; Koelker M; Alkhatib K; Lughezzani G; Buffi NM; Lipsitz SR; Weissman JS; Fletcher SA; Kibel AS; Trinh QD; Cole AP
Prostate; 2023 Aug; 83(11):1099-1111. PubMed ID: 37150867
[TBL] [Abstract][Full Text] [Related]
3. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
[TBL] [Abstract][Full Text] [Related]
4. Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals.
Krimphove MJ; Fletcher SA; Cole AP; Berg S; Sun M; Lipsitz SR; Mahal BA; Nguyen PL; Choueiri TK; Kibel AS; Kluth LA; Weissman JS; Trinh QD
J Urol; 2019 Apr; 201(4):735-741. PubMed ID: 30414956
[TBL] [Abstract][Full Text] [Related]
5. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL
Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344
[TBL] [Abstract][Full Text] [Related]
6. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic Cancer in the United States.
Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
[TBL] [Abstract][Full Text] [Related]
9. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
[TBL] [Abstract][Full Text] [Related]
10. Income inequality and treatment of African American men with high-risk prostate cancer.
Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
[TBL] [Abstract][Full Text] [Related]
11. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.
Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Lago-Hernandez C; Choueiri TK; Elfiky AA; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Kim SP; Lathan CS; Trinh QD; Nguyen PL
J Geriatr Oncol; 2014 Oct; 5(4):352-8. PubMed ID: 24862107
[TBL] [Abstract][Full Text] [Related]
13. Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate Cancer.
Hougen HY; Swami N; Dee EC; Alshalalfa M; Meiyappan K; Florez N; Penedo FJ; Nguyen PL; Punnen S; Mahal BA
JCO Oncol Pract; 2023 Aug; 19(8):645-653. PubMed ID: 37262399
[TBL] [Abstract][Full Text] [Related]
14. The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.
Fletcher SA; Gild P; Cole AP; Vetterlein MW; Kibel AS; Choueiri TK; Sonpavde GP; Preston MA; Pucheril D; Menon M; Sun M; Lipsitz SR; Trinh QD
Urol Oncol; 2018 May; 36(5):238.e7-238.e17. PubMed ID: 29454591
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
[TBL] [Abstract][Full Text] [Related]
16. Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
Ramey SJ; Asher D; Kwon D; Ahmed AA; Wolfson AH; Yechieli R; Portelance L
Gynecol Oncol; 2018 Apr; 149(1):53-62. PubMed ID: 29605051
[TBL] [Abstract][Full Text] [Related]
17. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population.
Lichtensztajn DY; Leppert JT; Brooks JD; Shah SA; Sieh W; Chung BI; Gomez SL; Cheng I
J Natl Compr Canc Netw; 2018 Nov; 16(11):1353-1360. PubMed ID: 30442735
[No Abstract] [Full Text] [Related]
18. Racial differences in patient-reported outcomes among men treated with radical prostatectomy for prostate cancer.
Koelker M; Labban M; Frego N; Ye J; Lipsitz SR; Hubbell HT; Edelen M; Steele G; Salinas K; Meyer CP; Makanjuola J; Moore CM; Cole AP; Kibel AS; Trinh QD
Prostate; 2024 Jan; 84(1):47-55. PubMed ID: 37710385
[TBL] [Abstract][Full Text] [Related]
19. Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study.
Katz JE; Chinea FM; Patel VN; Balise RR; Venkatramani V; Gonzalgo ML; Ritch C; Pollack A; Parekh DJ; Punnen S
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):533-538. PubMed ID: 29988097
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in Health Care Resource Utilization After Pediatric Cervical and/or Thoracic Spinal Injuries.
Elsamadicy AA; Sandhu MR; Freedman IG; Koo AB; Hengartner AC; Reeves BC; Havlik J; Sarkozy M; Hong CS; Kundishora AJ; Tuason DA; DiLuna M
World Neurosurg; 2021 Dec; 156():e307-e318. PubMed ID: 34560297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
